Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Morin: Natural Flavonoid Antioxidant for Energy Metabolis...

    2026-04-07

    Morin: Natural Flavonoid Antioxidant for Energy Metabolism Research

    Introduction: The Promise of Morin in Translational Research

    Morin (CAS 480-16-0), chemically known as 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, is a bioactive natural flavonoid compound isolated from Maclura pomifera. Recognized for its diverse applications as a natural flavonoid antioxidant, cardioprotective and neuroprotective agent, and fluorescent aluminum ion probe, Morin has emerged as an essential tool for investigating oxidative stress, mitochondrial energy metabolism, and inflammation signaling pathways. Its relevance spans disease models of diabetes, cancer, and neurodegenerative disorders, with mechanistic studies revealing potent inhibition of adenosine 5′-monophosphate deaminase (AMPD)—a pivotal factor in cellular energy regulation and podocyte protection. Sourced at 98% purity from APExBIO, Morin enables robust, reproducible research workflows for scientists seeking reliable solutions in disease biology and biochemical assay development.

    Principle Overview: Mechanism, Bioactivity, and Analytical Advantages

    Bioactivity and Mechanistic Insights

    Morin exerts multiple bioactivities, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, anti-diabetic, and antimicrobial effects. Mechanistically, Morin modulates biological pathways associated with oxidative stress and inflammation. A crucial breakthrough, highlighted in Yang et al. (2025), demonstrates that Morin acts as a mitochondrial energy metabolism modulator by inhibiting AMPD activity. This inhibition stabilizes cellular ATP levels, particularly in podocytes exposed to high fructose, thus preventing mitochondrial dysfunction and subsequent cell injury—a key insight for diabetic kidney injury research.

    Analytical Application: Fluorescent Probe for Metal Ions

    Beyond its therapeutic relevance, Morin is distinguished as a fluorescent chelating agent. Its unique electronic structure allows selective binding to metal ions, especially aluminum, making it highly effective as a fluorescent aluminum ion detection probe in biochemical assays. This dual utility bridges disease model research with sensitive analytical workflows.

    Physicochemical and Storage Properties

    • Molecular Formula: C15H10O7
    • Molecular Weight: 302.24
    • Solubility: ≥19.53 mg/mL in DMSO; ≥6.04 mg/mL in ethanol; insoluble in water
    • Purity: ~98% (HPLC, MS, NMR validated)
    • Recommended Storage: -20°C

    Experimental Workflow: Step-by-Step Protocol Enhancements

    1. Preparation of Morin Stock Solutions

    • Weigh out Morin (SKU C5297) under low-light conditions (to prevent photodegradation).
    • Dissolve in DMSO (preferred for highest solubility: ≥19.53 mg/mL), or ethanol (secondary choice: ≥6.04 mg/mL).
    • Filter sterilize using a 0.22 μm syringe filter if using for cell culture applications.
    • Aliquot and store stocks at -20°C. Avoid repeated freeze-thaw cycles and prolonged exposure to light. For optimal performance, use freshly prepared solutions within one week.

    2. In Vitro Assay Integration

    • For cell-based studies (e.g., podocyte, cancer, or neuronal cell lines), dilute Morin stock to working concentrations (typically 1–50 μM) directly into cell culture media.
    • Include vehicle-only (DMSO or ethanol) controls at matched concentrations for all treatment groups.
    • For mitochondrial function assays (such as Seahorse XF or Clark-type electrode), pre-incubate cells with Morin for 12–24 hours before measuring oxygen consumption rate (OCR) and ATP production.

    3. Biochemical Assays: Aluminum Ion Detection

    • Prepare Morin-based probe solution in ethanol or DMSO.
    • Mix with buffered samples containing variable concentrations of aluminum ions.
    • Detect binding by measuring fluorescence emission at ~515 nm upon excitation at 410–420 nm.
    • Calibrate with known standards for quantitative metal ion analysis.

    4. In Vivo Workflow: Disease Model Studies

    • For diabetes or kidney injury models, administer Morin (typically 10–100 mg/kg/day) via oral gavage or intraperitoneal injection, as used in Yang et al. (2025).
    • Monitor endpoints such as urinary albumin-to-creatinine ratio, mitochondrial ultrastructure, and AMPD activity in tissue lysates.

    Advanced Applications and Comparative Advantages

    Morin as a Strategic Probe in Metabolic and Disease Research

    Morin’s validated inhibition of adenosine 5′-monophosphate deaminase distinguishes it from other flavonoids, directly linking it to mitochondrial energy metabolism modulation. In diabetes research, Yang et al. (2025) demonstrated that Morin significantly reduced podocyte foot process effacement and restored glomerular synaptopodin expression in high-fructose models. The study quantified that Morin suppressed AMPD activity by over 40% and improved mitochondrial ATP production, with comparable efficacy to genetic AMPD2 knockdown.

    Morin’s fluorescent chelating properties further enable dual-use in both disease biology and analytical workflows. As detailed in the thought-leadership article "Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one): Mechanistic Modulation and Analytical Promise", Morin’s selectivity for aluminum ions makes it a cost-effective alternative to synthetic probes in environmental and biological monitoring.

    Comparative Insights: Why Morin Outperforms Alternatives

    • Purity and Reproducibility: APExBIO’s Morin offers batch-to-batch consistency (98% purity), surpassing generic sources and ensuring reliable assay performance (complementary guidance).
    • Multi-Modal Utility: Simultaneously serves as a mitochondrial energy metabolism modulator and a fluorescent probe—streamlining workflows for researchers in cancer biology, diabetes, and neurodegenerative disease models.
    • Mechanistic Specificity: Direct inhibition of AMPD, confirmed by both molecular docking and functional assays, provides a unique mechanistic handle for dissecting energy stress responses (contrasting with broader-acting flavonoids).

    Troubleshooting and Optimization Tips

    Solubility and Handling

    • Challenge: Poor aqueous solubility may limit Morin’s use in some cell culture or assay systems.
    • Tip: Always dissolve Morin in high-grade DMSO for maximal solubility. Ensure the final DMSO concentration in biological assays does not exceed 0.1–0.2% to avoid cytotoxicity.

    Stability and Storage

    • Challenge: Degradation upon repeated freeze-thaw or prolonged exposure to light.
    • Tip: Aliquot stocks under amber vials and store at -20°C. Use within one week for optimal antioxidant and fluorescence activity.

    Assay Interference

    • Potential Issue: Morin’s natural fluorescence may overlap with emission spectra of other assay reagents.
    • Solution: Validate excitation/emission parameters in preliminary runs. For multi-fluorophore applications, stagger filter sets or use time-resolved fluorescence where possible.

    Data Interpretation Controls

    • In all functional assays, include both vehicle and positive controls (e.g., known AMPD inhibitors) to benchmark Morin’s bioactivity.
    • For mitochondrial assays, verify that observed effects are not due to solvent or off-target cytotoxicity by monitoring cell viability in parallel.

    Case Example: Podocyte Energy Metabolism Assay

    In Yang et al. (2025), researchers optimized Morin dosing by titrating from 1 to 50 μM in vitro, observing maximal AMPD inhibition and mitochondrial protection at 20 μM without cytotoxicity. Key troubleshooting included ensuring complete Morin solubilization and pre-incubation time adjustment (12–24 hours) for robust readouts.

    Future Outlook: Expanding the Utility of Morin in Biomedical Research

    Morin’s dual roles—as both a disease model modulator and a biochemical probe—position it at the forefront of translational research. Ongoing developments include:

    • Precision Medicine: Exploiting Morin’s targeted inhibition of AMPD2 for personalized interventions in diabetic nephropathy and metabolic syndrome.
    • Multiplex Assays: Combining Morin’s antioxidant and fluorescent properties in high-throughput screening platforms for drug discovery.
    • Neurodegenerative Disease Models: Leveraging its neuroprotective and mitochondrial stabilizing effects in Alzheimer’s and Parkinson’s disease research (an extension of current paradigms).
    • Environmental and Clinical Diagnostics: Expanding Morin’s use as a sensitive, selective aluminum ion detection probe in biological and environmental samples.

    With its validated performance, high purity, and reliable supply from APExBIO, Morin is poised to remain an indispensable asset for experimentalists and translational scientists alike. For ready-to-use, quality-controlled Morin, visit the APExBIO product page.